Role of a Designated Pharmacist in Reducing Adverse Drug Reaction Rates and Preventing Potential Medication Errors in Hematology-Oncology: A Randomized Controlled Trial

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Randomized controlled trial shows reduced adverse drug reactions and enhanced medication error detection in oncology patients.

The intervention group had significantly lower rates of adverse drug reactions, suggesting pharmacist involvement is beneficial.
Results indicated an age-adjusted hazard ratio of 0.38 for at least one adverse drug reaction among those receiving pharmacist intervention.
The methods employed a randomized controlled trial design to assess the pharmacist's impact on reducing medication errors.
These findings highlight the importance of integrating pharmacists into hematology-oncology clinics for improved patient safety.

Alabbasi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark